Apex Labs approved for US-based secondary GMP psilocybin supplier by Health Canada
Apex Labs Ltd. a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, announces Health Canada
Latest Press Releases
The 'Press Releases' section offers the latest product-specific and company-related updates to our esteemed clients, providing them with a valuable resource. Members can leverage this platform for quick, efficient, and effective visibility.
— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.
— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.
Novaliq announces FDA approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for dry eye disease treatment
Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, had announced that the U.S. Food and Drug Administration (FDA) has approved VEVYE™ (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease.
Univar Solutions expands specialty pharmaceutical and nutraceutical ingredient portfolios with Grace SYLOID
Univar Solutions Inc. a leading global solutions provider to users of specialty ingredients and chemicals, today announced the Company has reached an agreement with W. R. Grace & Co. ("Grace") to distribute Grace's SYLOID® FP silica for pharmaceutical and nutraceutical markets in the majority of European countries*.
AYVAKIT® as the First and Only Treatment for Indolent Systemic Mastocytosis
Blueprint Medicines Corporation announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT® (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM). All U.S. patients with ISM now have access to the first and only approved medicine designed to treat their disease.
Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term
Abbott announced its Assert-IQ™ insertable cardiac monitor (ICM) has received U.S. Food and Drug Administration (FDA) clearance, giving physicians a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats.
CardieX Receives FDA 510(K) Clearance for a World-First Vascular Biometric Monitor
CardieX Limited announced its new arterial health monitor, the CONNEQT Pulse (Pulse), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Sai Life Sciences opens SSRL, a dedicated research facility
Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), announced the opening of Sai Schrödinger Research Laboratories (SSRL).
Bridgewest Group completes acquisition of sterile injectable manufacturing plant
Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, announces that it has completed the acquisition of the Perth sterile injectable manufacturing facility from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc.
Sintetica US launches Lidocaine Hydrochloride Injection
Sintetica S.A., an international pharmaceutical company with manufacturing facilities in Switzerland, announces the launch of Lidocaine Hydrochloride Injection, USP 1%, 2% and 4% through its subsidiary Sintetica US.
Dr. Anton Jorgensen begins lumbar total Joint replacement clinical trial
Anton Jorgensen, MD and Ortho San Antonio has announced the first cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, as an alternative to lumbar spinal fusion surgery. Dr. Jorgensen completed the surgeries at the Foundation Surgical Hospital of San Antonio.